'Flip Fido Customers to Chatr': Rogers Stock (TSE:RCI.B) Ticks Up Despite Customer Service Concerns
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Rogers noted that it has '…made changes to our vendor mix,' but did not specifically mention layoffs at Foundover, which handled its customer service contracts. The layoffs included technical support staff and customer care reps, as well as managers for those teams and '…all call centre positions,' one report noted. Rogers itself noted that customers '…increasingly use digital tools and self-services,' which in turn meant Rogers needed to make '…some changes to our vendor mix.'
Foundover, for its part, denied laying off 1,000 people, and would not share exact numbers. But former employees of Rogers' suggest that Rogers is increasingly looking to letting artificial intelligence step in to handle customer service issues. Fido, a 'flanker brand,' turns to an AI chatbot and virtual assistant to handle calls, and Rogers also required employees to use an AI tool to '…track their calls,' one report noted. Rogers was reportedly obliging its employees to '…flip Fido customers to Chatr, and Chatr customers to Rogers.'
Satellite-to-Mobile Service Goes Live
Rogers is also starting up the beta version of a new service, a satellite-to-mobile text messaging service that opens up a huge swath of Canadian real estate for at least some kind of coverage. In fact, coverage now extends over 5.4 million square kilometers of Canadian ground thanks to the service. The beta is actually free to join, and once the beta ends this October, Rogers Ultimate Plan users get the service for free. Other plans will have it available, though at C$15 per month with a discount for anyone who was in the beta.
Users will be able to get in on not only text messaging, but also text-to-911 service. Rogers will not stop there, though, as future updates are planned and will offer access to apps and data, and even, eventually, voice service. Voice over internet service is not exactly new; 10 years ago they called it 'VoIP.' But seeing it put to use more extensively today is a welcome development.
Is Rogers Communications a Good Stock to Buy?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on TSE:RCI.B stock based on seven Buys and three Holds assigned in the past three months, as indicated by the graphic below. After a 12% loss in its share price over the past year, the average TSE:RCI.B price target of C$51.82 per share implies 13.47% upside potential.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
2 hours ago
- CNBC
With another tariff deadline looming, these 10 things are going the right way for stocks
Conventional wisdom holds that as we get closer and closer to the coming deadline for tariff resolution, the market will become more treacherous, especially for highly valued stocks. I don't know who writes these stories. I always check the bylines and I have never worked with them or hired them. I will tell you this: their lack of knowledge of how the market works is painful. Their shoddy knowledge of market history would never be tolerated in any classroom. They are, what we used to call at The Harvard Crimson, "filler-up stories," meaning stories that had to be written because copy was needed. In truth, while the deadline looms, there is no relation between the highly valued stocks and the events at hand. I actually expect severe news about South Korea and Japan before Aug. 1 — the Trump administration's "hard deadline," in the words of Commerce Secretary Howard Lutnick, for when new country-specific duty rates will come into effect. Korean car companies "make" vehicles here, but the White House would argue to you that all they do is assemble them here, while the more highly valued pieces of a car are made in the home country. Japan makes even less here but is defended, like Korea, by our soldiers, and I could see President Donald Trump invoking that fact to put on some capricious number — call it 35% tariffs on their imports — because that level is eye-grabbing. So, I doubt we're even going to get to the drop dead date of Aug. 1 without more drama. Does anyone who trades or invests think that the tariffs will influence the most highly valued stocks, none other than my newly minted cohort called PARC — Palantir , Applovin , Robinhood and Coinbase ? These all have room to run because if you are willing to pay 100 times earnings it means nothing to pay 200. That's the gospel. How can these writers not know that? Can Palantir be stopped by Canadian tariffs? Oh please, and if crypto gets knocked down, it will get up again. It's never going to keep that down. Let's flip this moment on its head and question what's buoying the near-record market as second-quarter earnings season picks up steam (we have five Club names reporting this week). I have 10 things on the list, some already happening and others more forward-looking. First, and most obvious: earnings have been terrific. Yes, there is an occasional Abbott Labs , which was brutalized by China, or Netflix , which was challenged by sky-high expectations. But the banks have set the tone, and the pastiche that closed out the week all came in very strong. I expect that to continue, with the only potential weak spot being the drugmakers. Just not enough blockbusters and some very weak pipelines. It's been a brutal year for health care overall, sitting last among all 11 sectors in the S & P 500 . Second, Trump's "big beautiful bill" contains so many provisions that will boost the economy that I think we need to rethink the possibility of a hobbled consumer. Consider these: An extension of the 2017 tax cuts that were set to expire at the end of this year, which could've resulted in an effective tax increase across income cohorts. This is particularly helpful for those who make less than $100,000. A tax deduction worth up to $25,000 for employees who earn tips, a huge win for the working class. Millions of U.S. workers stand to benefit from this. Increased standard deduction to $31,500 (from $30,000) for married joint filers and $15,750 (from $15,000) for single filers. That can make taxes easier to figure out and deliver a bigger benefit. Max child tax credit of $2,200 per child, up from $2,000, which impacts around 40 million families. Expanding 529 savings plans to cover workforce credentialing programs in areas like the trades. A new deduction on car loan interest for vehicles made in the U.S., capped at $10,000 a year. For higher earners, the size of the deduction is reduced. Tax-advantaged savings accounts for newborns, the so-called "Trump accounts." Some tax relief for seniors on Social Security benefits. These are huge benefits that will pump hundreds of billions in the U.S. economy and it's like no one ever cares. Tariffs are important. But these put money in the hands of spenders. Third, business get more tax relief on spending, building and research-and-development costs than anyone expected. Accelerated deductions and credit for building things will set off another boom. I talked about these in a previous piece . Every time I have ever seen this kind of relief, it generates far more spending and jobs than anyone expects. Fourth, we seem to be oblivious to how countries are signaling to Washington that they are going to make their companies build here in order to get some relief from the White House. There's also re-shoring to contend with. Sure, the White House may be circumspect about an Apple putting $500 billion into the U.S. economy in the next four years, but I'm not. Fifth, the amount of building that needs to be done for data centers and for the electric grid are so gigantic that they might be considered the equivalent of the biggest public works campaigns in history, and they include a huge labor component not often addressed. Don't forget that nuclear power overhauls are gigantic projects. Sixth, the Federal Reserve's new stress tests for banks will allow them to lend far more than they currently do. We forget how much heat there has been on the banks in the wake of the financial crisis to be incredibly conservative. That's over. Seventh, the opening of all sorts of land for drilling and the approval of a huge number of new pipelines will create a second renaissance of the U.S. energy sector. Eighth, two industries have so much business and are so important to the U.S. economy that they will be colossal sources of work: aerospace, where Boeing has to expand to meet new orders, and defense, where we are depleted by Ukraine. A heavy component in this sector is new kinds of weapons including drones. Ninth, the initial public offering market is primed and ready, and I think can create new jobs and new wealth for employees and sustained profits for the investment banks, which is why they are such great buys. We own Goldman Sachs for the Club. And finally No. 10, it's been so easy to bet against stocks for so long because the Biden administration had been so anti-business, particularly when it comes to mergers and acquisitions. That's over. Now short-sellers will be incredibly scared to lean on stocks. Witness the rally in the railroads last week that crushed shorts banking on weaker transport earnings. Now, again, Trump seems to do whatever is necessary to derail us in astounding fashion. But we need to think more creatively. When we hear talk of him firing Fed Chair Jerome Powell, what you need to think is that no matter what, lower rates lie ahead. I don't think it will be because of a weaker economy because of what I just detailed, but because Trump wants to have a gross domestic product boom so he can say we are the fastest-growing, most-powerful country in the world. That's what Make American Great Again stands for. Even if you think it is a gigantic fraud, remember that Trump — through a gigantic hole in the budget and pro-business agencies — has created the circumstances that could lead to the opposite of what the "filler-up stories" say will happen. (Jim Cramer's Charitable Trust is long GS and ABT. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Los Angeles Times
7 hours ago
- Los Angeles Times
Tariffs leading to less selection, higher prices for holiday shopping
With summer in full swing in the United States, retail executives are sweating a different season. It's less than 22 weeks before Christmas, a time when businesses that make and sell consumer goods usually nail down their holiday orders and prices. But President Donald Trump's vacillating trade policies, part of his effort to revive the nation's diminished manufacturing base and to reduce the U.S. deficit in exported goods, have complicated those end-of-year plans. Balsam Hill, which sells artificial trees and other decorations online, expects to publish fewer and thinner holiday catalogs because the featured products keep changing with the tariff — import tax — rates the president sets, postpones and revises. 'The uncertainty has led us to spend all our time trying to rejigger what we're ordering, where we're bringing it in, when it's going to get here,' Mac Harman, CEO of Balsam Hill parent company Balsam Brands, said. 'We don't know which items we're going to have to put in the catalog or not.' Months of confusion over which foreign countries' products may become more expensive to import has left a question mark over the holiday shopping season. U.S. retailers often begin planning for the winter holidays in January and typically finalize the bulk of their orders by the end of June. The seesawing tariffs already have factored into their calculations. The consequences for consumers? Stores may not have the specific gift items customers want come November and December. Some retail suppliers and buyers scaled back their holiday lines rather than risking a hefty tax bill or expensive imports going unsold. Businesses still are setting prices but say shoppers can expect many things to cost more, though by how much depends partly on whether Trump's latest round of 'reciprocal' tariffs kicks in next month. The lack of clarity has been especially disruptive for the U.S. toy industry, which sources nearly 80% of its products from China. American toy makers usually ramp up production in April, a process delayed until late May this year after the president put a 145% tariff on Chinese goods, according to Greg Ahearn, president and CEO of the Toy Association, an industry trade group. The late start to factory work in China means holiday toys are only now arriving at U.S. warehouses, industry experts said. A big unknown is whether tariffs will keep stores from replenishing supplies of any breakout hit toys that emerge in September, said James Zahn, editor-in-chief of the trade publication Toy Book. In the retail world, planning for Christmas in July usually involves mapping out seasonal marketing and promotion strategies. Dean Smith, who co-owns independent toy stores JaZams in Princeton, New Jersey, and Lahaska, Pennsylvania, said he recently spent an hour and a half running through pricing scenarios with a Canadian distributor because the wholesale cost of some products increased by 20%. Increasing his own prices that much might turn off customers, Smith said, so he explored ways to 'maintain a reasonable margin without raising prices beyond what consumers would accept.' He ordered a lower cost Crazy Forts building set so he would have the toy on hand and left out the kids' edition of the Anomia card game because he didn't think customers would pay what he would have to charge. 'In the end, I had to eliminate half of the products that I normally buy,' Smith said. Hilary Key, owner of The Toy Chest in Nashville, Indiana, said she tries to get new games and toys in early most years to see which ones she should stock up on for the winter holidays. This year, she abandoned her product testing for fear any delayed orders would incur high import taxes. Meanwhile, vendors of toys made in China and elsewhere bombarded Key with price increase notices. For example, Schylling, which makes Needoh, Care Bear collectibles and modern versions of nostalgic toys like My Little Pony, increased prices on orders by 20%, according to Key. All the price hikes are subject to change if the tariff situation changes again. Key worries her store won't have as compelling a product assortment as she prides herself on carrying. The retail industry may have to keep taking a whack-a-mole approach to navigating the White House's latest tariff ultimatums and temporary reprieves. Last week, the president again reset the rates on imports from Brazil, the European Union, Mexico, and other major trading partners but said they would not take effect until Aug. 1. The brief pause should extend the window importers have to bring in seasonal merchandise at the current baseline tariff of 10%. The Port of Los Angeles had the busiest June in its 117-year history after companies raced to secure holiday shipments, and July imports look strong so far, according to Gene Seroka, the port's executive director. 'In my view, we're seeing a peak season push right now to bring in goods ahead of potentially higher tariffs later this summer,' Seroka said Monday. Smith, who co-owns the two JaZams stores with his partner, Joanne Farrugia, said they started placing holiday orders two months earlier than usual for 'certain items that we felt were essential for us to have at particular pricing.' They doubled their warehouse space to store the stockpile. But some shoppers are trying to get ahead of higher prices just like businesses are, he said. He's noticed customers snapping up items that will likely be popular during the holidays, like Jellycat plush toys and large stuffed unicorns and dogs. Any sales are welcome, but Smith and Farrugia are wary of having to restock at a higher cost. 'We're just trying to be as friendly as we can to the consumer and still have a product portfolio or profile that is gonna meet the needs of all of our various customers, which is getting more and more challenging by the day,' Smith said. D'Innocenzio and Anderson write for the Associated Press.
Time Business News
8 hours ago
- Time Business News
Pharma & Research Laboratories in Canada
Canada is recognized as a world leader in pharmaceutical research, development, and innovation. Highly equipped Pharmaceutical Laboratories and a regulatory structure that favours growth give the country a leading edge in medical and biotech advances. If you are a pharmaceutical company, healthcare provider, or a biotech start-up, the potential for partnerships with a reputable Canadian lab is both broad and profound. Pharmaceutical laboratories play a crucial role in developing safe and effective drugs and treatments for patients. These laboratories are key to: Conducting clinical research and trials. Developing new drugs and formulations. Maintaining compliance with quality standards and regulations. Advancing vaccine and biotechnology research. There are numerous reasons the world owes Pharma Laboratories a great debt for the company's significant contributions to public health. They are the unsung heroes of modern medicine, from cancer research to vaccine development. Lab Canada has been expanding at an unprecedented pace in the last few years. With strong government support, significant investment in research and development, and a highly skilled workforce, Canadian labs are making notable strides in pharmaceutical science. Canada is listed as one of the world's leaders in clinical trials, biologics research, and biotech innovation. The Canada lab has some of the best good manufacturing practices (GMP-compliant) and technology in the industry, which is unmatched anywhere. Many of these labs are also ISO-certified, meaning they adhere to international quality standards and maintain a safe testing environment. Most Canadian Pharmaceutical Laboratories Offer services that cater to all aspects of the pharmaceutical development cycle. These include: Analytical Services: Analysis for chemicals, stability testing, and testing of raw materials. Analysis for chemicals, stability testing, and testing of raw materials. Formulation: Dosage formulation including tablets, capsules, AND injectables, etc. Dosage formulation including tablets, capsules, AND injectables, etc. Microbiology Testing: Testing for harmful microorganisms in products. Testing for harmful microorganisms in products. Regulatory Submission: Supply relevant information for regulatory filings. Supply relevant information for regulatory filings. Bioavailability & Bioequivalence Studies: Efficacy of the drug being compared with the standard. From small batch testing to vast pharmaceutical manufacturing, be assured that Canadian Analytical Laboratories is our trusted partner in innovation and dependability. When choosing a laboratory, reliability, compliance, and innovation are non-negotiable. Here are some reasons why getting a Canadian lab is a good business decision: Elite Level Standards: Canadian labs comply with Health Canada & FDA standards. Canadian labs comply with Health Canada & FDA standards. Cutting-edge Technology: These laboratories are equipped with the best-of-breed tools, from AI-powered analytics to robotics automation. These laboratories are equipped with the best-of-breed tools, from AI-powered analytics to robotics automation. Expertise & Talent: With highly educated chemists, biologists, and lab techs, quality is a given. With highly educated chemists, biologists, and lab techs, quality is a given. Nut Data Integrity: Security and accuracy should be maintained in all testing activities. Security and accuracy should be maintained in all testing activities. Teamwork: Easily collaborate with research and manufacturing teams worldwide. Pharma Labs also services more than drug manufacturers. These include: Biotechnology Companies Healthcare Providers Nutraceutical Brands Academic and Research Institutions Veterinary Medicine Providers From diagnostics to commercial production, Laboratories Canada delivers tailored services to different industries. Laboratory needs continue to evolve in response to global health threats. Canada is investing heavily in AI for diagnostics, personalized medicine, and green chemistry. The future of Pharma Laboratories in Canada is bright, sustainable, and innovative. In today's fast-paced world, having the right partner can make all the difference when developing innovative pharmaceutical products. Pharma Laboratories Canada upholds the highest standards of quality, innovation, and compliance among its partnered drug developers and industry professionals in the pharmaceutical, biotechnology, and healthcare sectors. Whether you're introducing a new drug or in the process of testing, having a Canadian laboratory means your project is in reliable hands. When it comes to Research and Development, Canada laboratory represents trust, effectiveness, and innovation. Q1. What are the services provided by Pharma Laboratories in Canada? A: They provide analytical testing, formulation development, microbiology testing, support for clinical trials, and regulatory consulting. Q2. Do Canadian laboratories meet the international standard? A: Yes, most Canadian labs comply with GMP, ISO certifications, and follow FDA and Health Canada regulations. Q3. How Do I Find the Best Canadian Lab for My Project? A: Look at lab accreditation, experience, technology, turnaround times, and customer reviews. Q4. Do foreign pharmaceutical companies support Canadian labs? A: Absolutely, Canadian labs frequently partner with overseas clients and provide comprehensive services, including logistics, documentation, and regulatory applications. Q5. These labs are only for drugs? A: No, they additionally cater to the biotechnology, nutraceuticals, academic research, and veterinary sectors. TIME BUSINESS NEWS
